689 related articles for article (PubMed ID: 8686357)
1. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
2. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
3. [Proton-pump inhibitors versus H2-receptor antagonists in triple therapy for Helicobacter pylori eradication].
Kanayama S
Nihon Rinsho; 1999 Jan; 57(1):153-6. PubMed ID: 10036954
[TBL] [Abstract][Full Text] [Related]
4. [Eradication of Helicobacter pylori infection in Hungary (1993-2002): a meta-analysis].
Buzás GM
Orv Hetil; 2003 Jun; 144(22):1077-83. PubMed ID: 12847817
[TBL] [Abstract][Full Text] [Related]
5. [Medico-economic aspects of the treatment of duodenal ulcer: from antisecretory treatment to eradication of Helicobacter pylori].
Carrère MO; Auquier P; Poynard T; Sambuc R
Gastroenterol Clin Biol; 1995 Dec; 19(12):1023-30. PubMed ID: 8729415
[TBL] [Abstract][Full Text] [Related]
6. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
[TBL] [Abstract][Full Text] [Related]
7. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of tetracycline and metronidazole alone or with ranitidine on the healing of duodenal ulcer and eradication of Helicobacter pylori. A randomized controlled multicenter study. Tetra-Metro-Ran Study Group.
Massarrat S; Ihm P; Koch HK
Arzneimittelforschung; 1998 Jun; 48(6):686-90. PubMed ID: 9689428
[TBL] [Abstract][Full Text] [Related]
9. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Bardhan KD
Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
[TBL] [Abstract][Full Text] [Related]
10. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
11. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
Vergara M; Catalán M; Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
14. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis: the influence of pre-treatment with a proton pump inhibitor on Helicobacter pylori eradication.
Janssen MJ; Laheij RJ; de Boer WA; Jansen JB
Aliment Pharmacol Ther; 2005 Feb; 21(4):341-5. PubMed ID: 15709984
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
17. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
Graham DY; Hammoud F; El-Zimaity HM; Kim JG; Osato MS; El-Serag HB
Aliment Pharmacol Ther; 2003 May; 17(10):1229-36. PubMed ID: 12755836
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of clarithromycin in eradicating Helicobacter pylori.
Satoh K; Kimura K; Takimoto T; Kihira K; Taniguchi Y; Saifuku K
J Gastroenterol; 1996 Nov; 31 Suppl 9():53-5. PubMed ID: 8959520
[TBL] [Abstract][Full Text] [Related]
20. H2-receptor antagonists an Helicobacter pylori eradication.
Lamers CB
Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
